Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

R&D 100 Award 2014 for ZEISS ELYRA P.1 with 3D-PALM

Published: Thursday, July 24, 2014
Last Updated: Thursday, July 24, 2014
Bookmark and Share
ZEISS is receiving Research & Development award once more.

ZEISS ELYRA P.1 with 3D-PALM has been selected by the expert judges and editors of R&D Magazine as a recipient of a 2014 R&D 100 Award. The patented exclusive PALM technology of ZEISS ELYRA P.1 is regarded as one of 100 most significant high-technology products introduced in the past year.

As its name suggests, the 3D-PALM module enables superresolution photoactivated localization microscopy (PALM) in 3D. With ELYRA P.1 and 3D-PALM, researchers can capture highly resolved structures in 3D using photo-switchable proteins, while treating the sample so gently it stays fit for long-term observation.

Detection with an effective resolution down to 20 nm shows substructures and patterns where conventional light microscopy will simply show co-localization.

The technology has been supported by the Federal Ministry of Education and Research (German abbreviation: BMBF) as part of the project "Optical Technologies (biophotonics)".

The R&D 100 Awards celebrate the year's top technology products in the fields of new materials, chemical research, biomedical products and high-energy physics.

The winners come from the areas of industry, science, private research institutes and government laboratories. Since 2002, ZEISS has won one of the renowned awards every year.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

50 Years of Scanning Electron Microscopy from ZEISS
ZEISS celebrates the birth of the first commercial scanning electron microscope in 1965.
Saturday, August 08, 2015
ZEISS and UC Berkeley Launch Public-Private Partnership
Microscopy tools optimized for use with emerging neurotechnologies provided for researchers.
Saturday, June 13, 2015
ZEISS Announces Partnership with ECR Engines
Providing analytical microscopes for NASCAR Engine Producer.
Saturday, April 04, 2015
Bessel Beam Plane Illumination Microscopy Enables Fast 3D Volume Imaging
ZEISS and the Janelia Research Campus sign an exclusive license agreement for commercialization.
Tuesday, September 16, 2014
ZEISS Acquires Xradia
X-ray microscopy solutions close the gap between light and electron microscopy.
Friday, July 19, 2013
New in ZEISS Online Campus: Spectral Imaging and Fluorescence Proteins
Fluorescence microscopy training course on the Internet
Friday, October 23, 2009
Scientific News
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Genetic Cause of Rare Allergy
Institute has identified a genetic mutation responsible for a rare form of inherited hives induced by vibratory urticaria.
Battery Component Found to Harm Key Soil Microorganism
The material at the heart of the lithium ion batteries that power electric vehicles, laptop computers and smartphones has been shown to impair a key soil bacterium, according to new research.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!